Orforglipron (Foundayo) New for 2026 The newest addition to the metabolic toolkit, this is a non-peptide oral medication recently approved by the FDA
Beans, lentils, oats, barley, vegetables, fruits, nuts, and seeds help nutrients travel farther along the digestive tract to where GLP-1 is released
Semaglutide and the retina: Weighing evidence against concern
UK outlook for GLP-1 Diabetes Treatment Drugs Market Revenue from GLP-1 diabetes treatment drugs in the United Kingdom is projected to grow at a CAGR of 21.5% through 2035, supported by the country's healthcare system development, advanced diabetes care capabilities, and established expertise in pharmaceutical solutions
Interestingly, in clinical trials for 2.4 mg semaglutide, only 0.2% of 407 participants reported a burning sensation, which highlights the importance of proper injection technique
How to Mix (Reconstitute) Our peptide vials typically hold up to 3 mL of liquid